Macular Degeneration Association

Therapeutic Areas: Oncology | Hematology

Hematologic Neoplasms Clinical Trials

A listing of Hematologic Neoplasms medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Arizona

UPDATED

Scottsdale Arizona 85259-5499

A clinical trial to evaluate treatments using SAR650984, pomalidomide and dexamethasone for patients with Haematological Malignancy

Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Hematologic Neoplasms

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

California

Los Angeles California 90027

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Illinois

Chicago Illinois 60637

Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer

Maryland

UPDATED

Baltimore Maryland 21287

A Phase 1 clinical study for patients with Hematologic Neoplasms

Massachusetts

UPDATED

Boston Massachusetts 02114

A clinical trial to evaluate treatments using SAR650984, pomalidomide and dexamethasone for patients with Haematological Malignancy

UPDATED

Boston Massachusetts 02115

A clinical trial to evaluate treatments using SAR650984, pomalidomide and dexamethasone for patients with Haematological Malignancy

UPDATED

Boston Massachusetts 02215

A Phase 1 clinical study for patients with Hematologic Neoplasms

New York

UPDATED

New York New York 10021

A Phase 1 clinical study for patients with Hematologic Neoplasms

North Carolina

UPDATED

Charlotte North Carolina 28204

A clinical trial to evaluate treatments using SAR650984, pomalidomide and dexamethasone for patients with Haematological Malignancy

Oregon

UPDATED

Portland Oregon 97239

A Phase 1 clinical study for patients with Hematologic Neoplasms

South Carolina

Greenville South Carolina 29605

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Texas

UPDATED

Houston Texas 77030

A Phase 1 clinical study for patients with Hematologic Neoplasms

Dallas Texas 75390

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Houston Texas 77030

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

San Antonio Texas 78229

A Phase 1 clinical study for patients with Hematologic Neoplasms

Virginia

Fairfax Virginia 22031

Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer

Washington

UPDATED

Seattle Washington 98109

A Phase 1 clinical study for patients with Hematologic Neoplasms

France

UPDATED

Lille

Patients are needed to participate in a clinical research study of OTX015 to evaluate Acute Leukemia or Other Hematological Malignacies

UPDATED

Paris

Patients are needed to participate in a clinical research study of OTX015 to evaluate Acute Leukemia or Other Hematological Malignacies

Israel

UPDATED

Tel Aviv

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Italy

UPDATED

Torino

Patients are needed to participate in a clinical research study of OTX015 to evaluate Acute Leukemia or Other Hematological Malignacies

Spain

UPDATED

Barcelona

A clinical research study of Ibrutinib and Nivolumab for the treatment of Hematologic Neoplasms, Hematologic Malignancies

Switzerland

UPDATED

Bellinzona

Patients are needed to participate in a clinical research study of OTX015 to evaluate Acute Leukemia or Other Hematological Malignacies

France

Paris 75014

A clinical research study of Vemurafenib for the treatment of Solid Tumors, Hematologic Cancers or Metastatic Cancers

Villejuif Ile de France 94805

A clinical research study of Crizotinib for the treatment of Hematologic Cancers, Solid Tumors or Metastatic Cancer

Germany

Frankfurt 60590

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Munster 48129

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Italy

Rome 00161

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Japan

Fukuoka

A Phase 1 clinical study for patients with Blood Cancer or Advanced B Cell Malignancies

Isehara Kanagawa

A Phase 1 clinical study for patients with Blood Cancer or Advanced B Cell Malignancies

Kashiwa Chiba 277-8577

A clinical trial seeking patients for a research study of Oral azacitidine

Nagoya-shi Aichi

A Phase 1 clinical study for patients with Blood Cancer or Advanced B Cell Malignancies

Tokyo 104-0045

A clinical trial seeking patients for a research study of Oral azacitidine

Tokyo 135-8550

A clinical trial seeking patients for a research study of Oral azacitidine

Poland

Wroclaw 50-368

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)